Neuropharmacology of zonisamide, a new antiepileptic drug
- 1 January 1987
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 18 (3) , 303-307
- https://doi.org/10.1016/0306-3623(87)90016-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Zonisamide in Epilepsy: A Pilot StudyEpilepsia, 1985
- Pilot Study of Zonisamide (1,2‐Benzisoxazole‐3‐methanesulfonamide) in Patients with Refractory Partial SeizuresEpilepsia, 1985
- Nonlinear Pharmacokinetics of CI-912 in Adult Epileptic PatientsTherapeutic Drug Monitoring, 1984
- EFFECTS OF "3-SULFAMOYLMETHYL-1,2-BENZISOXAZOLE (AD-810) AND SOME ANTI-EPILEPTICS ON THE KINDLED SEIZURES IN THE NEOCORTEX, HIPPOCAMPUS AND AMYGDALA IN RATS1981
- Effect of acetazolamide on barbiturate-induced sleeping time in mice. II. Effect on barbiturate levels in the plasma and brain.CHEMICAL & PHARMACEUTICAL BULLETIN, 1980
- Relationships Between Plasma Concentrations of Diphenylhydantoin, Phenobarbital, Carbamazepine, and 3‐Sulfamoylmethyl‐1,2‐Benzisoxazole (AD‐810), a New Anticonvulsant Agent, and Their Anticonvulsant or Neurotoxic Effects in Experimental AnimalsEpilepsia, 1979
- Relations Between Structure and Biological Activity of SulfonamidesAnnual Review of Pharmacology and Toxicology, 1976
- Enhancement of the chlorpromazine-induced suppression of the conditioned avoidance response by carbonic anhydrase inhibitionNeuropharmacology, 1974
- Influence of carbonic anhydrase inhibition on hypothermic response and brain distribution of chlorpromazineToxicology and Applied Pharmacology, 1970
- Carbonic anhydrase: chemistry, physiology, and inhibitionPhysiological Reviews, 1967